Main Capital sells TPSC to PE-backed Symplr

Symplr expects to further expand its healthcare governance, risk and compliance platform by including patient safety and incident tracking and reporting.

It also plans to enlarge its offering by addressing the full spectrum of healthcare labour regulatory requirements, while also improving patient outcomes and quality of service.

Furthermore, the combined group intends to drive consolidation in the industry, accelerate its organic growth and penetrate new markets.

Main Capital acquired a majority stake in TPSC in June 2014 via its €40m Main Capital III fund.

Company
Founded in 2003 as GreCom and rebranded in 2009, TPSC specialises in providing governance, risk and compliance software to the healthcare industry. Its cloud-based platform allows healthcare organisations to automate and support a series of processes, including incident management, quality improvement and accreditation.

The company is headquartered in Alkmaar, the Netherlands, with a US branch located in Stamford, Connecticut. Its client base is composed of around 250 healthcare institutions, such as hospitals, mental health departments and ambulatory care providers.

In addition to local customers across the Netherlands, which include the Academic Medical Center Amsterdam and UMC Utrecht, the company sells its software through an international network in 19 countries with North America and Australia being its largest international markets.

People
Clearlake Capital – Prashant Mehrotra, Paul Huber (partners).
SkyKnight Capital – Jordan Milich, Claude Burton (partners).
Main Capital Partners – Pieter van Bodegraven (partner).
The Patient Safety Company – Rick Bergen (CEO).
Symplr – Rick Pleczko (CEO).

Advisers
Equity – Healthcare Growth Partners (corporate finance).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• Benelux
• Technology
• Healthcare
• Main Capital
• Netherlands
• Trade sale